MassChallenge Startups Create Impact

2,928

Startups Accelerated

$8.6B

Funding Raised

$3.6B

Revenue Generated

186K+

Jobs Created

Our startups

Be inspired. Search our startups.

Clear  
GlamorousAI

GlamAI proprietary platform, Rosalind, is the first AI platform to focus entirely on diseases where only a little information is available, a challenge that is currently intractable by other approaches. In weeks, Rosalind identified a hitherto undiscovered, nonetheless synthesizable hit candidate for the notoriously challenging and commercially attractive oncology target. Rosalind is not specific to any therapeutic area.
Glamorous AI has a novel approach to chemical design and optimisation that focuses of areas where only limited data is available.

Connect with GlamorousAI

GlamorousAI

2021

2021 Finalist BOS-96

Sub industry

Therapeutics (Pharma / Biotech)

Mission

Our mission is to equip bold entrepreneurs to disrupt the status quo and to create meaningful change.